SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

ImmunoCellular Therapeutics, Ltd. (IMUC)

IMUC RSS Feed
Add IMUC Price Alert      Hide Sticky   Hide Intro
Moderator: Investor100
Search This Board:
Last Post: 9/28/2016 11:21:27 AM - Followers: 146 - Board type: Free - Posts Today: 0

 


 

 

ImmunoCellular Therapeutics continues to make significant progress in meeting important goals and positioning the company for success. We believe that our cancer vaccine platform has the potential to be transformative in the treatment of cancer, and to create value for all our stakeholders. Our goal is to build ImmunoCellular into a leading, independent commercial-stage cancer immunotherapy company.





Our dendritic cell (DC) vaccine technology and advanced manufacturing offer several advantages over earlier-generation cellular immunotherapies:

Potency
- Matured DCs secrete IL12, which is critical for stimulating T cell killing of cancer cells.
More than 80% of the final manufactured product consists of matured DCs.

Versatility
- Unlike other cell-based vaccines, our DCs target multiple antigens, thus increasing the likelihood of effective treatment.

Efficiency
- Advanced manufacturing enables production of at least 20 doses of vaccine from a single apheresis (blood collection); thus patients do not need to undergo additional apheresis procedures.

Cost-effectiveness
- Compared to the only approved cell-based immunotherapy, our DC vaccines can be manufactured at a significantly reduced cost.

Convenience
- Ability to freeze and store vaccine for months or years eliminates the need to administer to the patient shortly after manufacture.
- Intradermal administration route reduces the time and inconvenience of intravenous infusion for both patient and physician.


Company Information:

21900 Burbank, 3rd Floor
Woodland Hills, CA 91367

Phone: 818-992-2907

http://www.imuc.com 

-
Management:
  
http://imuc.com/team/

Technologies:   http://imuc.com/technology/

Press Releases:   http://imuc.com/press/

http://finance.yahoo.com/q/h?s=IMUC+Headlines
 

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0000822411&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 -

Transfer Agent:

U.S. Stock Transfer Corp.
Suite 200
Glendale, CA 91204-2991

 Investor Relations:

Gary Nash, CEOcast, Inc.

Tel: (212)732-4300
Email: IR@imuc.com




 

 PIPELINE 







http://www.imuc.com/pipeline/ict-107/ict-107-faq

http://www.imuc.com/pipeline/ict-121

http://www.imuc.com/pipeline/ict-140



 UPDATE 



ImmunoCellular has concluded a phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. ImmunoCellular's pipeline also includes: ICT-121, a dendritic cell vaccine targeting CD133; ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells; and the Stem-to-T-cell research program which engineers the patient's hematopoietic stem cells to generate antigen-specific cancer killing T-cells.

Announced the establishment of an agreement with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma (GBM). This agreement with PharmaCell, a leading European contract manufacturing organization focuses on the production of human cell therapy products, and is designed to enable ImmunoCellular to access phase 3 supplies of ICT-107, manufactured with ImmunoCellular's commercial-ready production process. ImmunoCellular intends to initiate a Phase 3 registrational program for ICT-107 in the US and in Europe in 2015
.   


>>> What these CANCER vaccines could be worth
 

 NEW  


Investor Presentation -> http://files.shareholder.com/downloads/AMDA-1HS8HT/61684022x0x652321/5FD13B20-8F93-44CE-994E-D5515E5F30FC/IMI_Corporate_Overview.pdf 



 

 

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IMUC
Current Price
Volume:
Bid Ask Day's Range
SureTrader
IMUC News: Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) 09/23/2016 04:18:14 PM
IMUC News: Cryoport and Database Integrations Launch Integrated Solution to Manage Patient and Manufacturer Schedules at Every Stage of ... 09/22/2016 04:15:00 PM
IMUC News: Current Report Filing (8-k) 09/16/2016 01:44:10 PM
IMUC News: Current Report Filing (8-k) 09/01/2016 04:49:05 PM
IMUC News: Current Report Filing (8-k) 08/22/2016 04:32:20 PM
PostSubject
#3582   Vaccine plays: IMUC & GOVX. remind2 09/28/16 11:21:26 AM
#3581   Just like what hopefulsurgeonc indicates TODAY: better situated maverick_1 09/27/16 04:58:20 PM
#3580   You can buy 1 million shares for $120,000 dlangend_02 09/27/16 04:48:53 PM
#3579   EVERYONE here has been SO WRONG... and SO maverick_1 09/27/16 04:26:36 PM
#3578   Looking like a 40:1 split coming soon? Muvucker 09/23/16 09:34:45 PM
#3577   Holding IMUC until the end Stoxx1 09/18/16 04:46:11 PM
#3576   Nothing worse than reading posts that end with Muvucker 09/18/16 01:23:35 PM
#3575   From a fellow respected observer vs another : maverick_1 09/13/16 02:37:29 PM
#3574   IMUC ~ When has the company ever said Top Penny 09/10/16 01:45:36 PM
#3573   IMUC ~ Just stumbled across this, looks interesting. Top Penny 09/10/16 12:59:56 PM
#3572   Come on Nickel...quickly so we can scalp/ trade it. $MulaWin55$ 09/06/16 11:47:05 AM
#3571   IMUC: Top GBM Play...http://streetregister.com/2016/09/02/immunocellular-therape $MulaWin55$ 09/06/16 08:53:12 AM
#3570   IMUC RS will be good n great!!!,Look what $MulaWin55$ 09/04/16 11:58:34 PM
#3569   You never know in bio world what can Stoxx1 09/04/16 10:01:11 PM
#3568   Yes, they appear to have nothing that can Valensio 09/03/16 12:32:44 PM
#3567   Anyone think IMUC will reverse split? Stoxx1 09/02/16 07:44:16 PM
#3566   * * $IMUC Video Chart 09-02-16 * * ClayTrader 09/02/16 04:18:24 PM
#3565   He's not accurate naked shorts are,if he was 2014turnaround 09/02/16 12:34:00 PM
#3564   Sept 1 SEC 8K filing: REVERSE STOCK SPLIT maverick_1 09/02/16 11:37:54 AM
#3563   That and ClayTrader is all it takes. He's KDK 09/02/16 10:49:00 AM
#3562   * * $IMUC Video Chart 09-01-16 * * ClayTrader 09/01/16 05:05:53 PM
#3561   Turn off the lights...shorting and dilution killed this one. sigma213 09/01/16 03:42:44 PM
#3560   This goes nothing but down! Vincent1974 09/01/16 03:26:00 PM
#3559   Ouch!!! $MulaWin55$ 09/01/16 03:12:26 PM
#3556   Right On...woot woot.,made the pps healthier...almost got a $MulaWin55$ 09/01/16 10:44:00 AM
#3555   This stock will never reach even .20C IMO. sdmy123 09/01/16 10:36:08 AM
#3553   IMUC .17 p/m at one point. Wow ClearlyStocks 09/01/16 09:17:56 AM
#3552   Really Yuuuugggeee... http://reviewfortune.com/2016/08/31/latest-immunocellular- $MulaWin55$ 09/01/16 06:52:13 AM
#3551   YUUUUUUGGGGEEE!!!! freshy 08/31/16 05:45:21 PM
#3550   * * $IMUC Video Chart 08-31-16 * * ClayTrader 08/31/16 04:52:34 PM
#3549   Just got in this big 2 days ago. TheSaint09 08/31/16 04:39:47 PM
#3548   Looking for 20's Cmiller14 08/31/16 03:56:13 PM
#3547   Should gap up tomorrow, based on this volume. Never_Post 08/31/16 03:53:07 PM
#3546   IMUC $.158 ClearlyStocks 08/31/16 03:49:29 PM
#3545   IMUC $.155 ClearlyStocks 08/31/16 03:47:20 PM
#3544   IMUC .15 ClearlyStocks 08/31/16 03:44:45 PM
#3543   IMUC .147 ClearlyStocks 08/31/16 03:43:28 PM
#3542   IMUC .14 GAP fill coming PAC 08/31/16 03:37:05 PM
#3541   Highest volume day ever. Never_Post 08/31/16 03:30:29 PM
#3540   IMUC .145 ClearlyStocks 08/31/16 03:21:27 PM
#3539   IMUS .142 key break is .145 ClearlyStocks 08/31/16 03:02:27 PM
#3538   IMUC .13s looks like she wants to go ClearlyStocks 08/31/16 02:53:12 PM
#3537   Sure get the feeling that this wants to breakout. Never_Post 08/31/16 12:59:04 PM
#3536   Yeah, look out, def good for some scalping action. ccharon86 08/31/16 11:32:56 AM
#3535   Got a small pump article this morning: RNsidersbuying 08/31/16 11:04:42 AM
#3534   Here we go... Dannyboy7272 08/29/16 03:19:01 PM
#3533   Huge selling? Why???? JCB5 08/29/16 10:43:46 AM
#3532   IMUC @ Stockcharts Investor100 08/22/16 06:20:30 PM
#3531   Presentations @ IMUC Investor100 08/22/16 06:17:32 PM
#3530   2Q financials and business update http://m.nasdaq.com/press-release/immunocellu DivergentDeviate 08/19/16 05:09:36 PM
PostSubject